Luciane H Gargaglioni Selected Research

Luciane H Gargaglioni Research Topics

Disease

26	Hypoxia (Hypoxemia) 01/2022 - 09/2002
21	Hypercapnia 01/2022 - 11/2007
5	Hyperventilation 10/2020 - 04/2003
3	Hypothermia 01/2021 - 05/2005
3	Fever (Fevers) 01/2017 - 05/2007
2	COVID-19 11/2020 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
1	Tachypnea 01/2021
1	Acidosis 01/2018
1	Hypertension (High Blood Pressure) 11/2016
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2015

Drug/Important Bio-Agent (IBA)

9	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 05/2005
3	Estradiol (Delestrogen)FDA LinkGeneric 11/2017 - 10/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 08/2004
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2016 - 08/2004
3	Kynurenic Acid (Kynurenate)IBA 01/2011 - 04/2003
2	LipopolysaccharidesIBA 01/2021 - 05/2007
2	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 01/2021 - 04/2016
2	OrexinsIBA 12/2020 - 04/2016
2	Progesterone FDA LinkGeneric 11/2020 - 10/2017
2	Oxygen (Dioxygen)IBA 01/2020 - 05/2005
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 01/2018
2	GasesIBA 01/2020 - 11/2019
2	Gonadal HormonesIBA 12/2019 - 10/2017
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2017 - 08/2009
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2016 - 11/2004
2	Glutamic Acid (Glutamate)FDA Link 01/2011 - 04/2003
2	salicylhydroxamic acid (SHAM)IBA 02/2010 - 03/2008
2	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 09/2008 - 08/2004
2	Methysergide (Sansert)FDA Link 08/2006 - 05/2005
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 08/2006 - 05/2005
2	SB 269970IBA 08/2006 - 05/2005
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2003 - 09/2002
2	Ibotenic AcidIBA 08/2003 - 09/2002
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022
1	SaporinsIBA 01/2021
1	EndotoxinsIBA 01/2021
1	Dopamine beta-HydroxylaseIBA 01/2021
1	Pharmaceutical PreparationsIBA 11/2020
1	MuscimolIBA 11/2020
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 11/2020
1	Androgen Receptors (Androgen Receptor)IBA 10/2020
1	Flutamide (Eulexin)FDA LinkGeneric 10/2020
1	Testosterone (Sustanon)FDA Link 10/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Cannabinoid Receptor AntagonistsIBA 01/2020
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	AM 251 (AM251)IBA 01/2020
1	Angiotensin-Converting Enzyme 2IBA 01/2020
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 01/2019
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2018
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2017
1	Hormones (Hormone)IBA 10/2017
1	AntipyreticsIBA 01/2017
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2016
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2016
1	Ringer's SolutionIBA 11/2016
1	antalarminIBA 11/2016
1	(3,6- dimethyl- 2- (2,4,6- trimethylphenoxy)pyridin- 4- yl)(1- ethylpropyl)amineIBA 11/2016
1	NitratesIBA 01/2016
1	valproic acid glucuronideIBA 08/2012
1	Ionotropic Glutamate ReceptorsIBA 01/2011
1	Opioid Analgesics (Opioids)IBA 08/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2009
1	delta Opioid Receptors (delta Opioid Receptor)IBA 08/2009
1	Opioid Receptors (Opioid Receptor)IBA 08/2009
1	naltrindoleIBA 08/2009
1	norbinaltorphimineIBA 08/2009
1	5-HT1A Serotonin ReceptorIBA 08/2006
1	Serotonin ReceptorsIBA 05/2005
1	Excitatory Amino AcidsIBA 11/2004
1	Arginine (L-Arginine)FDA Link 08/2004
1	erythroagglutinating phytohemagglutininIBA 10/2003
1	AcidsIBA 09/2002

Therapy/Procedure

3	Ovariectomy (Oophorectomy) 01/2021 - 07/2015
2	Injections 01/2019 - 01/2018
2	Induced Hypothermia 11/2007 - 05/2005
1	Controlled Hypotension 11/2016